上海三友医疗器械股份有限公司关于注销部分募集资金专项账户的公告

Fundraising Overview - The company successfully completed its initial public offering (IPO) on March 12, 2020, raising a total of RMB 1,075,950,160.00, with a net amount of RMB 978,057,381.28 after deducting issuance costs [2] - The company was also approved to issue shares for asset acquisition and raise matching funds, totaling RMB 213,999,988.12, with a net amount of RMB 203,920,127.60 after related expenses [3] Fund Management - The company has established a dedicated account for fundraising, adhering to regulatory requirements and ensuring strict supervision of fund usage [5] - The company has signed a tripartite supervision agreement with its financial advisor and the bank holding the funds to ensure proper management [4] Account Cancellation - The company has decided to cancel a specific fundraising account at Shanghai Pudong Development Bank, as the excess funds from the IPO have been fully utilized [7] - The cancellation process has been completed, and the corresponding supervision agreement has been terminated [7]